Mirae Asset Global Investments Co. Ltd. Raises Stake in Cardinal Health, Inc. (NYSE:CAH)

Mirae Asset Global Investments Co. Ltd. boosted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 35.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 32,520 shares of the company's stock after buying an additional 8,471 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in Cardinal Health were worth $3,871,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of CAH. Perpetual Ltd purchased a new stake in Cardinal Health in the third quarter valued at approximately $208,000. UMB Bank n.a. boosted its position in Cardinal Health by 4.9% in the third quarter. UMB Bank n.a. now owns 2,249 shares of the company's stock valued at $249,000 after buying an additional 106 shares during the last quarter. Pinnacle Bancorp Inc. boosted its position in Cardinal Health by 20.0% in the third quarter. Pinnacle Bancorp Inc. now owns 690 shares of the company's stock valued at $76,000 after buying an additional 115 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its position in Cardinal Health by 868.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,799 shares of the company's stock valued at $641,000 after buying an additional 5,200 shares during the last quarter. Finally, Gateway Investment Advisers LLC boosted its position in Cardinal Health by 10.0% in the third quarter. Gateway Investment Advisers LLC now owns 6,120 shares of the company's stock valued at $676,000 after buying an additional 555 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

NYSE CAH traded down $1.30 during mid-day trading on Wednesday, hitting $127.09. The stock had a trading volume of 2,771,646 shares, compared to its average volume of 2,388,005. The firm's 50 day moving average is $122.66 and its 200 day moving average is $115.83. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The stock has a market capitalization of $30.70 billion, a price-to-earnings ratio of 23.71, a PEG ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio is currently 37.69%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CAH. Barclays upped their target price on Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a research report on Monday, November 4th. Mizuho assumed coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price target for the company. Citigroup boosted their price target on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a report on Friday, January 10th. JPMorgan Chase & Co. boosted their price target on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Finally, Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $136.87.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.